Matt Hall serves as Director of Corporate Development for Anika Therapeutics, and the company's global operations are headquartered outside of Boston.
2 reports, 1 independent
Updated Jul 17
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Matt Hall serves as Director of Corporate Development for Anika Therapeutics, and the company's global operations are headquartered outside of Boston.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- GlobeNewswireAnika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 BEDFORD, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation
- Unknown outlet